Market Overview:
The global iron drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of anemia, rising geriatric population, and growing demand for oral and intravenous (IV) iron drugs. Based on type, the global iron drugs market is segmented into oral drug and IV drug. The oral drug segment is expected to account for a larger share of the market in 2018 owing to its ease of use and lower cost as compared to IV drugs. However, the IV drug segment is projected to grow at a higher CAGR during the forecast period due its better efficacy in treating anemia as compared to oral drugs. Based on application, the global iron drugs market is divided into hospital, pharmacy/drugstore, and others segments. The hospital segment accounted for majority share of this market in 2017 due high prevalence rate of anemia among hospitalized patients across different geographies worldwide coupled with increasing number of surgical procedures being performed globally each year that leads increase demand for blood transfusions which further increases demand for intravenous Iron Drugs products .However ,the pharmacy/drugstore Segment Is Expected To Grow At A Higher Rate During Forecast Period Due To Rising Prevalence Of Anemia Among General Population And Increasing Number Of Pharmacies Across Globe .
Product Definition:
Iron Drugs are used to treat iron deficiency anemia. They work by restoring your body's iron levels, which helps your red blood cells carry oxygen throughout your body.
Oral Drug:
Oral drug, also known as oral medication or OTC drug is a pharmaceutical product that can be administered in the mouth. It's major application includes pain relief, anti-inflammatory drugs and antibiotics among others. The other important factor contributing to its growth include easy availability of these products over the counter which makes them easily accessible to all patients without any medical prescription needed.
IV Drug:
IV drugs are given to patients through IV infusion. These drugs can be administered in two ways, by vein or by injection into the muscle.
Application Insights:
Based on application, the market is segmented into hospital, drugstore and others. The others segment includes dental care facilities and veterinary hospitals/clinics. IV iron drugs are majorly used in the hospital sector as they can be administered directly to a patient¢â‚¬â„¢s vein without any prior preparation. However, there has been an increasing demand for oral iron drugs over the past few years owing to their ease of use, shorter duration of action and lower cost associated with them.
The drugstore application segment accounted for a revenue share of more than 40% in 2017 due to high usage rates coupled with low prices compared to other applications such as dentistry or veterinary clinics/hospitals.
Regional Analysis:
North America dominated the global iron drugs market in 2017. The presence of key pharmaceutical companies, availability of advanced healthcare facilities and high adoption rate for new medicines are some major factors responsible for its large share. In addition, increasing prevalence of chronic diseases such as cancer and anemia due to aging population is expected to drive the demand further. For instance, according to statistics published by American Cancer Society in 2018, around 1 million new cases were diagnosed in U.S that year and it is estimated that about 600 thousand people died due to it.
Growth Factors:
- Increasing prevalence of iron deficiency anemia: The increasing prevalence of iron deficiency anemia is one of the key growth drivers for the global Iron Drugs market. According to a study by World Health Organization (WHO), around 30% of the world’s population is affected by this condition, which is expected to increase in the coming years due to changing lifestyles and dietary habits. This will create a high demand for Iron Drugs products, thereby driving market growth.
- Rising awareness about benefits of early diagnosis and treatment: There is a growing awareness among people about the benefits of early diagnosis and treatment for iron deficiency anemia. This has led to an increase in demand for Iron Drugs products, propelling market growth.
- Growing number of pregnant women with iron deficiency: A large number of pregnant women are affected by iron deficiency each year, owing to their increased need for this mineral during pregnancy period. This is expected to drive market growth as more pregnant women will require treatment with Iron Drugs products in order to meet their daily requirement for this mineral..
Scope Of The Report
Report Attributes
Report Details
Report Title
Iron Drugs Market Research Report
By Type
Oral Drug, IV Drug
By Application
Hospital, Drugstore, Others
By Companies
Allergan, AMAG Pharmaceuticals, Daiichi Sankyo, Pharmacosmos, Vifor Pharma, Galenica, Nippon Shinyaku, Sanofi, Wanbang Biopharmaceutical, Allergan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Iron Drugs Market Report Segments:
The global Iron Drugs market is segmented on the basis of:
Types
Oral Drug, IV Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugstore, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- AMAG Pharmaceuticals
- Daiichi Sankyo
- Pharmacosmos
- Vifor Pharma
- Galenica
- Nippon Shinyaku
- Sanofi
- Wanbang Biopharmaceutical
- Allergan
Highlights of The Iron Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Drug
- IV Drug
- By Application:
- Hospital
- Drugstore
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Iron Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Iron drugs are medications that contain iron. Iron drugs can be used to treat a variety of conditions, including anemia and blood disorders.
Some of the major players in the iron drugs market are Allergan, AMAG Pharmaceuticals, Daiichi Sankyo, Pharmacosmos, Vifor Pharma, Galenica, Nippon Shinyaku, Sanofi, Wanbang Biopharmaceutical, Allergan.
The iron drugs market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Iron Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Iron Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Iron Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Iron Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Iron Drugs Market Size & Forecast, 2018-2028
4.5.1 Iron Drugs Market Size and Y-o-Y Growth
4.5.2 Iron Drugs Market Absolute $ Opportunity
Chapter 5 Global Iron Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Iron Drugs Market Size Forecast by Type
5.2.1 Oral Drug
5.2.2 IV Drug
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Iron Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Iron Drugs Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugstore
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Iron Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Iron Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Iron Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Iron Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Iron Drugs Market Size Forecast by Type
9.6.1 Oral Drug
9.6.2 IV Drug
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Iron Drugs Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugstore
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Iron Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Iron Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Iron Drugs Market Size Forecast by Type
10.6.1 Oral Drug
10.6.2 IV Drug
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Iron Drugs Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugstore
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Iron Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Iron Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Iron Drugs Market Size Forecast by Type
11.6.1 Oral Drug
11.6.2 IV Drug
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Iron Drugs Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugstore
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Iron Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Iron Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Iron Drugs Market Size Forecast by Type
12.6.1 Oral Drug
12.6.2 IV Drug
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Iron Drugs Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugstore
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Iron Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Iron Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Iron Drugs Market Size Forecast by Type
13.6.1 Oral Drug
13.6.2 IV Drug
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Iron Drugs Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugstore
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Iron Drugs Market: Competitive Dashboard
14.2 Global Iron Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 AMAG Pharmaceuticals
14.3.3 Daiichi Sankyo
14.3.4 Pharmacosmos
14.3.5 Vifor Pharma
14.3.6 Galenica
14.3.7 Nippon Shinyaku
14.3.8 Sanofi
14.3.9 Wanbang Biopharmaceutical
14.3.10 Allergan
